Vor Biopharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 22.75 M | $15.92 M | 0.00% | 33.23% |
| FMR LLC | 11/13/2024 | 7.07 M | $4.95 M | -0.07% | 10.33% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 6.36 M | $4.45 M | 0.00% | 9.29% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 2.47 M | $1.73 M | 100.00% | 3.60% |
| VANGUARD GROUP INC | 11/13/2024 | 1.95 M | $1.37 M | 0.00% | 2.85% |
| COWEN AND COMPANY, LLC | 11/12/2024 | 1.22 M | $854,413 | 100.00% | 1.78% |
| JOHNSON & JOHNSON | 11/13/2024 | 1.07 M | $752,261 | 0.00% | 1.57% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 756,011 | $529,208 | 52.64% | 1.10% |
| SARISSA CAPITAL MANAGEMENT LP | 11/14/2024 | 618,000 | $432.60 M | 0.00% | 0.90% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 487,654 | $341,359 | 100.00% | 0.71% |
| MAI CAPITAL MANAGEMENT | 11/07/2024 | 475,891 | $333,124 | 1.24% | 0.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 422,143 | $295,568 | -0.63% | 0.62% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 329,378 | $230,565 | -4.83% | 0.48% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 303,825 | $212,678 | -22.02% | 0.44% |
| EXCHANGE TRADED CONCEPTS, LLC | 10/10/2024 | 165,805 | $116,063 | 40.77% | 0.24% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 137,134 | $95,994 | 100.00% | 0.20% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 135,900 | $95,130 | -18.08% | 0.20% |
| MARSHALL WACE, LLP | 11/14/2024 | 116,635 | $81,645 | 43.79% | 0.17% |
| STATE STREET CORP | 11/14/2024 | 115,934 | $81,154 | 0.00% | 0.17% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 81,305 | $55,000 | 0.00% | 0.12% |
| ROSALIND ADVISORS, INC. | 10/30/2024 | 76,685 | $53,680 | 100.00% | 0.11% |
| BOLLARD GROUP LLC | 11/13/2024 | 55,555 | $39,000 | 0.00% | 0.08% |
| LMR PARTNERS LLP | 11/07/2024 | 51,111 | $35,778 | 0.00% | 0.07% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 50,300 | $35,210 | 100.00% | 0.07% |
| NOMURA HOLDINGS INC | 11/14/2024 | 41,495 | $29,047 | 100.00% | 0.06% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 30,825 | $21,578 | -67.68% | 0.05% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 29,530 | $20,671 | -53.32% | 0.04% |
| LAURION CAPITAL MANAGEMENT LP | 11/14/2024 | 28,981 | $20,287 | -98.85% | 0.04% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 28,227 | $19,759 | -92.48% | 0.04% |
| GROUND SWELL CAPITAL, LLC | 10/29/2024 | 26,103 | $18,272 | 26.26% | 0.04% |
| MONEY CONCEPTS CAPITAL CORP | 10/31/2024 | 25,000 | $17,500 | 25.00% | 0.04% |
| MORGAN STANLEY | 11/14/2024 | 24,448 | $17,114 | -85.56% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 24,219 | $16,953 | 0.00% | 0.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 17,792 | $12,454 | 0.00% | 0.03% |
| UNITED BANK | 11/15/2024 | 15,300 | $10,710 | 0.00% | 0.02% |
| GRIMES & COMPANY, INC. | 10/22/2024 | 15,142 | $10,599 | 0.00% | 0.02% |
| JANE STREET GROUP, LLC | 11/15/2024 | 13,761 | $9,633 | -93.82% | 0.02% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 10/29/2024 | 13,593 | $9,549 | -17.48% | 0.02% |
| JPMORGAN CHASE & CO | 11/08/2024 | 12,038 | $8,427 | 1,124.62% | 0.02% |
| BARCLAYS PLC | 11/19/2024 | 11,024 | $8,000 | -57.19% | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 11/14/2024 | 11,000 | $7,700 | 100.00% | 0.02% |
| 11/14/2024 | 9,800 | $6,860 | 0.00% | 0.01% | |
| CITADEL ADVISORS LLC | 11/14/2024 | 9,300 | $6,510 | 520.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 5,871 | $4,110 | -76.67% | 0.01% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 5,053 | $3,000 | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 4,298 | $3,009 | -72.47% | 0.01% |
| CITADEL ADVISORS LLC | 11/14/2024 | 713 | $499 | -99.16% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/06/2024 | 528 | $370 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 11/04/2024 | 200 | $140 | 0.00% | 0.00% |
| EAGLE BAY ADVISORS LLC | 10/22/2024 | 150 | $105 | 0.00% | 0.00% |
Vor Biopharma Inc.institutional Ownership - FAQ's
During the previous two years, 78 institutional investors and hedge funds held shares of Vor Biopharma Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 22.75 M
FMR LLC: 7.07 M
5AM Venture Management, LLC: 6.36 M
Hudson Bay Capital Management LP: 2.47 M
VANGUARD GROUP INC: 1.95 M
COWEN AND COMPANY, LLC: 1.22 M
69.87% of Vor Biopharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 49.70 M shares in the last 24 months. This purchase volume represents approximately $43.24 M in transactions.